We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street's Radar ... On January 17th, Barclays assigned a “Buy” rating on the stock with a $17 target price.

Barclays analyst Ramsey El Assal maintained a Buy rating on Global Payments (GPN – Research Report) today and set a price target of $125.00.

Barclays lowered the firm’s price target on Global Payments (GPN) to $125 from $135 and keeps an Overweight rating on the shares. The firm ...

No single company or government can finance all the AI infrastructure and energy needs required, Barclays Europe CEO, Francesco Ceccato, told Euronews. His comments came just before US President ...

Our Barclays Women's Super League game against Crystal Palace will now take place at Sutton United on Sunday, March 30 ...

Barclays Research today released a new Impact Series report, entitled “AI revolution: Meeting massive AI infrastructure demands.” Focused on the US, as the market leader for the technology ...

Barclays said it met its performance targets for 2024, including a return on tangible equity (RoTe) of 10.5% in line with ...

Barclays PLC's Q4 results showed a 24.3% increase in total income, driven by strong performance in UK and Investment Banking, despite a 4% ADR drop. Concerns arise from Barclays UK's credit ...

Barclays highlights Broadcom (NASDAQ:AVGO), Credo Technology (NASDAQ:CRDO), and Lumentum Holdings (NASDAQ:LITE) as additional AI beneficiaries. The firm upgraded Lumentum to Overweight from ...

Despite Chinese claims that DeepSeek was produced for a fraction of other established AI models, Alphabet, Amazon, Meta and ...